1.Silva, R, Mesquita, AR, Bessa, J et al. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 2008;152:656–669.
2.Oh, DH, Park, YC, Kim, SH.Increased glycogen synthase kinase-3beta mRNA level in the hippocampus of patients with major depression: a study using the stanley neuropathology consortium integrative database. Psychiatry Investig 2010;7:202–207.
3.Facci, L, Stevens, DA, Skaper, SD.Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity. Neuroreport 2003;14:1467–1470.
4.Szatmari, E, Habas, A, Yang, P, Zheng, JJ, Hagg, T, Hetman, M.A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons. J Biol Chem 2005;280:37526–37535.
5.Chen, P, Gu, Z, Liu, W, Yan, Z.Glycogen synthase kinase 3 regulates N-methyl-d-aspartate receptor channel trafficking and function in cortical neurons. Mol Pharmacol 2007;72:40–51.
6.De Sarno, P, Bijur, GN, Zmijewska, AA, Li, X, Jope, RS.In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors. Neurobiol Aging 2006;27:413–422.
7.Torrey, EF, Webster, M, Knable, M, Johnston, N, Yolken, RH.The stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000;44: 151–155.
8.Kim, S, Webster, MJ.The stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010;35:473–482.
9.Kim, S, Webster, MJ.Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 2010;15:326–336.
10.Beneyto, M, Kristiansen, LV, Oni-Orisan, A, McCullumsmith, RE, Meador-Woodruff, JH.Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007;32:1888–1902.
11.Karolewicz, B, Stockmeier, CA, Ordway, GA.Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression. Neuropsychopharmacology 2005;30:1557–1567.
12.Toro, C, Deakin, JF.NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 2005;80:323–330.
13.Beneyto, M, Meador-Woodruff, JH.Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008;33: 2175–2186.
14.Feyissa, AM, Chandran, A, Stockmeier, CA, Karolewicz, B.Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:70–75.
15.Karolewicz, B, Szebeni, K, Gilmore, T, Maciag, D, Stockmeier, CA, Ordway, GA.Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int J Neuropsychopharmacol 2009;12:143–153.
16.Sheng, M.The postsynaptic NMDA-receptor–PSD-95 signaling complex in excitatory synapses of the brain. J Cell Sci 2001;114:1251.
17.Cui, H, Hayashi, A, Sun, HS et al. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci 2007;27:9901–9915.
18.Khovryakov, AV, Podrezova, EP, Kruglyakov, PP et al. Involvement of the NO synthase system in stress-mediated brain reactions. Neurosci Behav Physiol 2010;40:333–337.
19.Zhou, QG, Hu, Y, Hua, Y et al. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. J Neurochem 2007;103:1843–1854.
20.Oliveira, RM, Guimaraes, FS, Deakin, JF.Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res 2008;41:333–341.
21.Camp, AJ, Wijesinghe, R.Calretinin: modulator of neuronal excitability. Int J Biochem Cell Biol 2009;41:2118–2121.
22.Fonseca, M, Soriano, E.Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease. Brain Res 1995;691:83–91.
23.Brandt, MD, Jessberger, S, Steiner, B et al. Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. Mol Cell Neurosci 2003;24:603–613.
24.Nitsch, R, Ohm, TG.Calretinin immunoreactive structures in the human hippocampal formation. J Comp Neurol 1995;360:475–487.
25.Zhang, ZJ, Reynolds, GP.A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 2002; 55:1–10.